News topic

ATC group V08AB09

Current shortage notices for the ATC group V08AB09, structured by product, country and reporting period.

15 notices

What the V08AB09 notices indicate for the supply chain

The 15 consolidated notices from Belgium, Germany are market and supply signals. They do not confirm current Inter-Pharma stock or a general ability to supply. Operational assessment requires separate verification of product status, batch, expiry, temperature requirements, recipient authorisation and the permitted distribution route.

GDP-capable pharmaceutical storage in Cheb

Inter-Pharma supports manufacturers, wholesalers and logistics partners with GDP-capable pharmaceutical storage in Czechia. Its own Cheb site enables project-specific buffer and safety stocks, batch and expiry control, FEFO, stock-status management, picking and dispatch preparation for Germany and Europe.

BelgiumUpdated 05.11.2026

Visipaque 270 mg I/ml inj. sol. i.thec./i.cavern./i.v./i.arter. vial 50 ml

Active ingredient: Iodixanol

ATC group V08AB09

What the V08AB09 notices indicate for the supply chain

GDP-capable pharmaceutical storage in Cheb

Visipaque 270 mg I/ml inj. sol. i.thec./i.cavern./i.v./i.arter. vial 50 ml

Visipaque 270 mg I/ml inj. sol. i.thec./i.cavern./i.v./i.arter. vial 100 ml

Visipaque 320

Visipaque 270

Visipaque 320 mg I/ml inj. sol. i.thec./i.cavern./i.v./i.arter. vial 50 ml

Visipaque 320 mg I/ml inj. sol. i.thec./i.cavern./i.v./i.arter. vial 100 ml

Visipaque 320

Visipaque 270

Visipaque 320 mg I/ml inj. opl. i.thec./i.cavern./i.v./i.arter. flac. 50 ml

Visipaque 320 mg I/ml inj. opl. i.thec./i.cavern./i.v./i.arter. flac. 200 ml

Visipaque 270 mg I/ml inj. opl. i.thec./i.cavern./i.v./i.arter. flac. 50 ml

Visipaque 270 mg I/ml inj. opl. i.thec./i.cavern./i.v./i.arter. flac. 100 ml

Visipaque 270

Visipaque 320

Visipaque 270

Plan supply. Connect sourcing and warehousing.

Improve sourcing and supply availability

Pharma warehouse and pharmaceutical warehousing in Cheb